サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1225396

ハンチントン病治療市場：種類、薬物タイプ、年齢、流通チャネル、エンドユーザー、地域別2023-2028

Huntington's Disease Treatment Market by Type, Drug Type, Age, Distribution Channel, End Users, and Region 2023-2028
出版日: | 発行: IMARC | ページ情報: 英文 147 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
ハンチントン病治療市場：種類、薬物タイプ、年齢、流通チャネル、エンドユーザー、地域別2023-2028
出版日: 2023年02月03日
発行: IMARC
ページ情報: 英文 147 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ハンチントン病治療の世界市場規模は、2022年に4億771万米ドルに達しました。今後、IMARCグループは、2023年から2028年の間に20.46%の成長率（CAGR）を示し、2028年までに12億8,031万米ドルに達すると予測しています。ハンチントン病の主な発展、先進的な治療薬に対する需要の増加、革新的な治療法の開発などが、市場を牽引する主な要因となっています。

ハンチントン病は、脳の神経細胞の破壊を進行させる致死的な神経変性疾患です。ハンチントン病の症状には、不随意運動、筋力障害、整理・集中困難、意識障害、不眠、引きこもりなど、さまざまな運動・精神・認知機能障害が含まれます。ハンチントン病の治療には、抗精神病薬、抗うつ薬、抗パーキンソン病薬、気分安定薬など、さまざまな薬剤が適用されます。また、言語療法、作業療法、理学療法、精神療法など、さまざまな治療が行われます。ハンチントン病治療は、運動障害や精神障害の症状を最小限に抑え、患者さんが新しい能力に短時間で適応できるよう支援し、対処法を開発するのに役立ちます。また、日常的な作業や会話の改善、姿勢やバランスの維持、生活の質の向上も支援します。

ハンチントン病治療の市場動向

  • 世界中でハンチントン病の発症率が上昇していることは、市場の成長を促す主要な要因の一つです。ハンチントン病治療薬は、不随意運動や身もだえ運動の抑制、舞踏病治療、暴発や興奮の抑制、筋力・柔軟性・バランス・協調性の強化などに広く用いられ、ひいては生活の質を高め、食事やコミュニケーション、歩行などの日常的なタスクを遂行する患者の能力を向上させることが可能です。さらに、ハンチントン病に関連する運動、認知、精神症状をコントロールするための高度な薬剤に対する需要の高まりが、市場成長の原動力となっています。また、ハンチントン病とその根本的な原因に対する理解が深まったことにより、新たな疾患修飾薬の開発が急速に進んでいることも、成長を促す要因となっています。さらに、変異型ハンチンチン（mTT）の産生レベルを低下させることでハンチントン病の成長を抑止する革新的な治療法の最近の開発は、市場にプラスの影響を及ぼしています。これとは別に、アンチセンスオリゴヌクレオチド（ASO）を使用して中枢神経系（CNS）全体でハンチンチン（HTT）メッセンジャーリボ核酸（mRNA）とそのタンパク質を標的とするアンチセンス技術の導入は、市場の成長を推進しています。さらに、複数の政府が新薬の開発を促進するためのイニシアチブをとっていることも、市場の成長にプラスに働いています。その他の要因としては、ハンチントン病に関する大衆の意識の高まり、医療業界の著しい成長、研究開発（R&D）活動への投資の増加、老年人口の増加、適応外薬物に対する需要の高まりなどがあり、市場の成長を後押しすると予想されます。

主要市場のセグメンテーション

  • IMARC Groupは、世界のハンチントン病治療市場の各セグメントにおける主要動向の分析と、2023年から2028年までの世界、地域、国レベルでの予測を行っています。当レポートでは、市場をタイプ、薬剤の種類、年齢、流通チャネル、エンドユーザーなどに基づいて分類しています。

タイプのインサイト

  • 対症療法
  • 疾患修飾療法
  • 当レポートでは、ハンチントン病治療市場をタイプ別に詳細に区分・分析しています。これには、対症療法と疾患修飾療法が含まれます。それ別と、対症療法が最も大きなセグメントを占めています。

薬剤タイプの洞察

  • 承認済み医薬品
  • テトラベナジン
  • ドイテトラベナジン
  • 適応外薬物
  • 本レポートでは、ハンチントン病治療市場の薬剤タイプに基づく詳細な区分と分析が提供されています。これには、承認済み医薬品（テトラベナジンおよびドゥテトラベナジン）と適応外医薬品が含まれます。報告書別と、承認済み医薬品が最大の市場シェアを占めています。

年齢別インサイト

  • 50歳未満
  • 50歳以上
  • 本レポートでは、ハンチントン病治療市場の年齢別詳細な区分と分析が行われています。これには50歳未満と50歳以上が含まれます。本レポートによれば、50歳未満が最大の市場シェアを占めています。

流通チャネルインサイト

  • ドラッグストアおよび小売薬局
  • 病院内薬局
  • オンライン薬局
  • 本レポートでは、流通チャネルに基づくハンチントン病治療市場の詳細な区分と分析が提供されています。これにはドラッグストアや小売店、病院、オンライン薬局が含まれます。報告書別と、ドラッグストアと小売薬局が最大の市場シェアを占めています。

エンドユーザーの洞察

  • 病院
  • 在宅医療
  • 専門クリニック
  • その他
  • 本レポートでは、ハンチントン病治療市場のエンドユーザー別の詳細な区分と分析が掲載されています。これには、病院、在宅医療、専門クリニック、その他が含まれます。

地域別インサイト

  • 北米
  • 米国
  • カナダ
  • アジア太平洋地域
  • 中国
  • 日本
  • インド
  • 韓国
  • オーストラリア
  • インドネシア
  • その他
  • 欧州
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • スペイン
  • ロシア
  • その他
  • ラテンアメリカ
  • ブラジル
  • メキシコ
  • その他
  • 中東およびアフリカ
  • また、北米（米国、カナダ）、アジア太平洋（中国、日本、インド、韓国、オーストラリア、インドネシア、その他）、欧州（ドイツ、フランス、英国、イタリア、スペイン、ロシア、その他）、中南米（ブラジル、メキシコ、その他）、中東・アフリカを含むすべての主要地域市場について包括的に分析を行っています。それ別と、ハンチントン病治療の市場規模は北米が最大でした。北米のハンチントン病治療市場を牽引する要因としては、大幅な技術進歩、医療インフラの急速な整備、ハンチントン病を患う人の増加などが挙げられます。

本レポートで回答した主な質問

  • ハンチントン病治療の世界市場はこれまでどのように推移してきたか、また今後数年間はどのように推移していくか？
  • ハンチントン病治療の世界市場における促進要因、市場抑制要因、機会とは？
  • 主要な地域市場とは？
  • 最も魅力的なハンチントン病治療市場を代表する国はどこか？
  • 市場のタイプ別区分は？
  • 薬剤の種類に基づく市場の内訳は？
  • 年齢別の市場内訳は？
  • 流通チャネル別の市場内訳は？
  • エンドユーザー別の市場内訳は？
  • 世界のハンチントン病治療市場の競合構造は？
  • ハンチントン病治療の世界市場における主要企業は？

目次

第1章 序文

第2章 調査手法と範囲

  • 調査の目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 予測手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要な産業動向

第5章 ハンチントン病治療の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 タイプ別市場内訳

  • 対症療法
    • 市場動向
    • 市場予測
  • 疾患修飾性治療薬
    • 市場動向
    • 市場予測

第7章 薬物タイプ別市場内訳

  • 承認済み医薬品
    • 市場動向
    • 主要セグメント
      • テトラベナジン
      • ドゥテトラベナジン
    • 市場予測
  • オフラベル医薬品
    • 市場動向
    • 市場予測

第8章 年齢別市場内訳

  • 50歳以下
    • 市場動向
    • 市場予測
  • 50歳以上
    • 市場動向
    • 市場予測

第9章 流通チャネル別市場内訳

  • ドラッグストア・薬局
    • 市場動向
    • 市場予測
  • 病院薬局
    • 市場動向
    • 市場予測
  • オンライン薬局
    • 市場動向
    • 市場予測

第10章 エンドユーザー別市場内訳

  • 病院
    • 市場動向
    • 市場予測
  • 在宅医療
    • 市場動向
    • 市場予測
  • スペシャリティクリニック
    • 市場動向
    • 市場展望
  • その他
    • 市場動向
    • 市場予測

第11章 地域別市場内訳

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場展望
  • アジア太平洋地域
    • 中国
      • 市場動向
      • 市場展望
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場展望
    • 韓国市場
      • 市場動向
      • 市場展望
    • オーストラリア
      • 市場動向
      • 市場展望
    • インドネシア
      • 市場動向
      • 市場展望
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場展望
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場展望
    • スペイン
      • 市場動向
      • 市場展望
    • ロシア
      • 市場動向
      • 市場展望
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場展望
    • メキシコ
      • 市場動向
      • 市場展望
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 国別市場内訳
    • 市場展望

第12章 促進要因、阻害要因、ビジネスチャンス

  • 概要
  • 促進要因
  • 抑制要因条件
  • ビジネスチャンス

第13章 バリューチェーン分析

第14章 ポーターズファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の度合い
  • 新規参入業者の脅威
  • 代替品の脅威

第15章 価格分析

第16章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • AOP Health
    • Apotex Inc.
    • Dr. Reddy's Laboratories Ltd.
    • H. Lundbeck A/S
    • Hikma Pharmaceuticals PLC
    • Lupin Limited
    • Prilenia Therapeutics
    • Sun Pharmaceutical Industries Limited
    • Teva Pharmaceutical Industries Ltd.
    • Vaccinex Inc.

本レポートに記載されている企業名は一部であり、全企業名は本レポートに記載されています。

図表

List of Figures

  • Figure 1: Global: Huntington's Disease Treatment Market: Major Drivers and Challenges
  • Figure 2: Global: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Huntington's Disease Treatment Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Huntington's Disease Treatment Market: Breakup by Drug Type (in %), 2022
  • Figure 6: Global: Huntington's Disease Treatment Market: Breakup by Age (in %), 2022
  • Figure 7: Global: Huntington's Disease Treatment Market: Breakup by Distribution Channel (in %), 2022
  • Figure 8: Global: Huntington's Disease Treatment Market: Breakup by End User (in %), 2022
  • Figure 9: Global: Huntington's Disease Treatment Market: Breakup by Region (in %), 2022
  • Figure 10: Global: Huntington's Disease Treatment (Symptomatic Treatment) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Huntington's Disease Treatment (Symptomatic Treatment) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Huntington's Disease Treatment (Disease-modifying Therapies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Huntington's Disease Treatment (Disease-modifying Therapies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Huntington's Disease Treatment (Approved Drugs) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Huntington's Disease Treatment (Approved Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Huntington's Disease Treatment (Off-label Drugs) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Huntington's Disease Treatment (Off-label Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Huntington's Disease Treatment (Below 50 Years) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Huntington's Disease Treatment (Below 50 Years) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Huntington's Disease Treatment (Above 50 Years) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Huntington's Disease Treatment (Above 50 Years) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Huntington's Disease Treatment (Drug Store and Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Huntington's Disease Treatment (Drug Store and Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Huntington's Disease Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Huntington's Disease Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Huntington's Disease Treatment (Online Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Huntington's Disease Treatment (Online Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Huntington's Disease Treatment (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Huntington's Disease Treatment (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Huntington's Disease Treatment (Homecare) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Huntington's Disease Treatment (Homecare) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Huntington's Disease Treatment (Specialty Clinics) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Huntington's Disease Treatment (Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Huntington's Disease Treatment (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Huntington's Disease Treatment (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: North America: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: North America: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: United States: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: United States: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Canada: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Canada: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Asia-Pacific: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Asia-Pacific: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: China: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: China: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Japan: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Japan: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: India: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: India: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: South Korea: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: South Korea: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Australia: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Australia: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Indonesia: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Indonesia: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Others: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Others: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Europe: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Europe: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Germany: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Germany: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: France: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: France: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: United Kingdom: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: United Kingdom: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Italy: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Italy: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Spain: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Spain: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Russia: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Russia: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Others: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Others: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Latin America: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Latin America: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Brazil: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Brazil: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Mexico: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Mexico: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Others: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Others: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Middle East and Africa: Huntington's Disease Treatment Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Middle East and Africa: Huntington's Disease Treatment Market: Breakup by Country (in %), 2022
  • Figure 84: Middle East and Africa: Huntington's Disease Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 85: Global: Huntington's Disease Treatment Industry: Drivers, Restraints, and Opportunities
  • Figure 86: Global: Huntington's Disease Treatment Industry: Value Chain Analysis
  • Figure 87: Global: Huntington's Disease Treatment Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Huntington's Disease Treatment Market: Key Industry Highlights, 2022 & 2028
  • Table 2: Global: Huntington's Disease Treatment Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Huntington's Disease Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2023-2028
  • Table 4: Global: Huntington's Disease Treatment Market Forecast: Breakup by Age (in Million US$), 2023-2028
  • Table 5: Global: Huntington's Disease Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 6: Global: Huntington's Disease Treatment Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 7: Global: Huntington's Disease Treatment Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 8: Global: Huntington's Disease Treatment Market: Competitive Structure
  • Table 9: Global: Huntington's Disease Treatment Market: Key Players
目次
Product Code: SR1423A237_Report

The global Huntington's disease treatment market size reached US$ 407.71 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,280.31 Million by 2028, exhibiting a growth rate (CAGR) of 20.46% during 2023-2028. The rising incidences of Huntington's disease, the increasing demand for advanced drugs for the disease treatment, and recent development of innovative therapeutic approaches represent some of the key factors driving the market.

Huntington's disease refers to a fatal neurodegenerative disorder that causes the progressive breakdown of nerve cells in the brain. Its symptoms include various movement, psychiatric, and cognitive impairments, such as involuntary jerking, muscle problems, difficulty in organizing and focusing, lack of awareness, insomnia, and social withdrawal. Huntington's disease treatment involves the application of various drugs, such as antipsychotics, antidepressants, antiparkinsonians, and mood-stabilizing drugs. The treatment process also includes various therapies, such as speech, occupational, physical, and psychotherapy. Huntington's disease treatment helps in minimizing the symptoms of movement and psychiatric disorders, assists patients in adapting to new abilities in a shorter time, and develops coping strategies. It also aids in improving everyday tasks, speech, maintaining posture and balance, and enhancing the quality of life.

Huntington's Disease Treatment Market Trends:

  • The rising incidence of Huntington's disease across the globe is one of the primary factors driving the market growth. Huntington's disease treatment is widely used to suppress involuntary jerking and writhing movement, treat chorea, reduce violent outbursts and agitation, and enhance strength, flexibility, balance, and coordination, which, in turn, improves the quality of life and enhances the patient's ability to carry out daily routine tasks, such as eating, communications, and walking. Furthermore, the increasing demand for advanced drugs to control the motor, cognitive, and psychiatric symptoms associated with Huntington's disease is providing an impetus to the market growth. In line with this, the rapid development of new disease-modifying drugs owing to the improved understanding of the disease, and its underlying causes are acting as another growth-inducing factor. Additionally, the recent development of the innovative therapeutic approach that deters the growth of Huntington's disease by reducing mutant huntingtin (mTT) production levels is positively influencing the market. Apart from this, the introduction of antisense technology that uses antisense oligonucleotides (ASOs) to target huntingtin (HTT) messenger ribonucleic acid (mRNA) and its protein throughout the central nervous system (CNS) is propelling the market growth. Moreover, increasing initiatives by several governments to promote the development of novel drugs are favoring the market growth. Other factors, including rising awareness among the masses regarding Huntington's disease, significant growth in the healthcare industry, increasing investment in research and development (R&D) activities, rising geriatric population, and escalating demand for off-label medications, are anticipated to drive the market growth.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each segment of the global Huntington's disease treatment market, along with forecasts at the global, regional, and country level from 2023-2028. Our report has categorized the market based on type, drug type, age, distribution channel, and end user.

Type Insights:

  • Symptomatic Treatment
  • Disease-modifying Therapies
  • The report has also provided a detailed breakup and analysis of the Huntington's disease treatment market based on the type. This includes symptomatic treatment and disease-modifying therapies. According to the report, symptomatic treatment represented the largest segment.

Drug Type Insights:

  • Approved Drugs
  • Tetrabenazine
  • Deutetrabenazine
  • Off-label Drugs
  • A detailed breakup and analysis of the Huntington's disease treatment market based on the drug type has been provided in the report. This includes approved drugs (tetrabenazine and deutetrabenazine) and off-label drugs. According to the report, approved drugs accounted for the largest market share.

Age Insights:

  • Below 50 Years
  • Above 50 Years
  • A detailed breakup and analysis of the Huntington's disease treatment market based on the age has been provided in the report. This includes below 50 years and above 50 years. According to the report, below 50 years accounted for the largest market share.

Distribution Channel Insights:

  • Drug Stores and Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
  • A detailed breakup and analysis of the Huntington's disease treatment market based on the distribution channel has been provided in the report. This includes drug store and retail, hospital, and online pharmacies. According to the report, drug store and retail pharmacies accounted for the largest market share.

End Users Insights:

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others
  • A detailed breakup and analysis of the Huntington's disease treatment market based on the end users has been provided in the report. This includes hospitals, homecare, specialty clinics, and others.

Regional Insights:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa
  • The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and Middle East and Africa. According to the report, North America was the largest market for Huntington's disease treatment. Some of the factors driving the North America Huntington's disease treatment market includes significant technological advancements, the rapid development of healthcare infrastructure, and the rising number of individuals suffering from Huntington's disease.

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the global Huntington's disease treatment market. Detailed profiles of all major companies have also been provided. Some of the companies covered include AOP Health, Apotex Inc., Dr. Reddy's Laboratories Ltd., H. Lundbeck A/S, Hikma Pharmaceuticals PLC, Lupin Limited, Prilenia Therapeutics, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Ltd., Vaccinex Inc. etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global Huntington's disease treatment market performed so far and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global Huntington's disease treatment market?
  • What are the key regional markets?
  • Which countries represent the most attractive Huntington's disease treatment markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the drug type?
  • What is the breakup of the market based on the age?
  • What is the breakup of the market based on the distribution channel?
  • What is the breakup of the market based on the end user?
  • What is the competitive structure of the global Huntington's disease treatment market?
  • Who are the key players/companies in the global Huntington's disease treatment market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Huntington's Disease Treatment Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Symptomatic Treatment
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Disease-modifying Therapies
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Drug Type

  • 7.1 Approved Drugs
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Tetrabenazine
      • 7.1.2.2 Deutetrabenazine
    • 7.1.3 Market Forecast
  • 7.2 Off-label Drugs
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Age

  • 8.1 Below 50 Years
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Above 50 Years
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Drug Store and Retail Pharmacies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hospital Pharmacies
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Online Pharmacies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Hospitals
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Homecare
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Specialty Clinics
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast
  • 10.4 Others
    • 10.4.1 Market Trends
    • 10.4.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 Drivers, Restraints, and Opportunities

  • 12.1 Overview
  • 12.2 Drivers
  • 12.3 Restraints
  • 12.4 Opportunities

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 AOP Health
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
    • 16.3.2 Apotex Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 SWOT Analysis
    • 16.3.3 Dr. Reddy's Laboratories Ltd.
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 H. Lundbeck A/S
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 Hikma Pharmaceuticals PLC
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 Lupin Limited
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
      • 16.3.6.4 SWOT Analysis
    • 16.3.7 Prilenia Therapeutics
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 Sun Pharmaceutical Industries Limited
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Teva Pharmaceutical Industries Ltd.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Vaccinex Inc.
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.